⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Supplementary Fig. 7 from Discovery and targeting of a noncanonical mechanism of sarcoma resistance to ADI-PEG20 mediated by the microenvironment

Leonard C. Rogers Jeff C. Kremer Caitlyn B. Brashears Zongtao Lin Zhixian Hu Alliny C.S. Bastos Adriana Baker Nicole Fettig Dong Zhou Kooresh I. Shoghi Carina Dehner John S.A. Chrisinger John S. Bomalaski Benjamin A. Garcia Toshinao Oyama Eileen White Brian A. Van Tine

View at Publisher

Ask AI

Bookmark

Share

Abstract

This is the authors' abstract. We don't add key points for this paper.

Supplemental Figure 7. Gemcitabine and docetaxel increase toxicity to ASS1 KO tumor cells treated with ADI-PEG20 and either chloroquine or imipramine.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rogers et al. (2024) studied this question.

synapsesocial.com/papers/68e58589b6db643587522734 https://doi.org/10.1158/1078-0432.27032365

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Fig. 7 from Discovery and targeting of a noncanonical mechanism of sarcoma resistance to ADI-PEG20 mediated by the microenvironment2024
2Supplementary Fig. 2 from Discovery and targeting of a noncanonical mechanism of sarcoma resistance to ADI-PEG20 mediated by the microenvironment2024
3Supplementary Fig. 2 from Discovery and targeting of a noncanonical mechanism of sarcoma resistance to ADI-PEG20 mediated by the microenvironment2024
4Supplementary Fig. 4 from Discovery and targeting of a noncanonical mechanism of sarcoma resistance to ADI-PEG20 mediated by the microenvironment2024
5Supplementary Fig. 4 from Discovery and targeting of a noncanonical mechanism of sarcoma resistance to ADI-PEG20 mediated by the microenvironment2024

Supplementary Fig. 3 from Discovery and targeting of a noncanonical mechanism of sarcoma resistance to ADI-PEG20 mediated by the microenvironment2024
Supplementary Fig. 3 from Discovery and targeting of a noncanonical mechanism of sarcoma resistance to ADI-PEG20 mediated by the microenvironment2024
Supplementary Fig. 5 from Discovery and targeting of a noncanonical mechanism of sarcoma resistance to ADI-PEG20 mediated by the microenvironment2024